Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3040416rdf:typepubmed:Citationlld:pubmed
pubmed-article:3040416lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3040416lifeskim:mentionsumls-concept:C0007807lld:lifeskim
pubmed-article:3040416lifeskim:mentionsumls-concept:C0028631lld:lifeskim
pubmed-article:3040416pubmed:issue1lld:pubmed
pubmed-article:3040416pubmed:dateCreated1987-10-20lld:pubmed
pubmed-article:3040416pubmed:abstractTextConcentrations of cyclic nucleotides--adenosine-3',5'-monophosphate (c-AMP) and guanosine-3',5'-monophosphate (c-GMP)--were measured in cerebrospinal fluid (CSF) of 17 drug-free Parkinson patients and 12 controls. No significant difference between the cyclic nucleotide contents (p greater than 0.05) in CSF of patients and controls was detected, nor was there a correlation between the content and the degree of neurological disability. Besides, no changes in the cyclic nucleotide contents were detected in the subgroups of patients according to the prominence of tremor or rigidity/akinesia as the main symptoms of the disease.lld:pubmed
pubmed-article:3040416pubmed:languageenglld:pubmed
pubmed-article:3040416pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040416pubmed:citationSubsetIMlld:pubmed
pubmed-article:3040416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040416pubmed:statusMEDLINElld:pubmed
pubmed-article:3040416pubmed:issn0014-3022lld:pubmed
pubmed-article:3040416pubmed:authorpubmed-author:MrsuljaB BBBlld:pubmed
pubmed-article:3040416pubmed:authorpubmed-author:Djurici?B MBMlld:pubmed
pubmed-article:3040416pubmed:authorpubmed-author:Nikoli?MMlld:pubmed
pubmed-article:3040416pubmed:authorpubmed-author:Kosti?V SVSlld:pubmed
pubmed-article:3040416pubmed:authorpubmed-author:Covickovi?-St...lld:pubmed
pubmed-article:3040416pubmed:authorpubmed-author:Bumbasirevi?-...lld:pubmed
pubmed-article:3040416pubmed:issnTypePrintlld:pubmed
pubmed-article:3040416pubmed:volume27lld:pubmed
pubmed-article:3040416pubmed:ownerNLMlld:pubmed
pubmed-article:3040416pubmed:authorsCompleteYlld:pubmed
pubmed-article:3040416pubmed:pagination24-8lld:pubmed
pubmed-article:3040416pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:meshHeadingpubmed-meshheading:3040416-...lld:pubmed
pubmed-article:3040416pubmed:year1987lld:pubmed
pubmed-article:3040416pubmed:articleTitleCyclic nucleotides in cerebrospinal fluid of drug-free Parkinson patients.lld:pubmed
pubmed-article:3040416pubmed:publicationTypeJournal Articlelld:pubmed